查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2018704

捐卵子體外受精服務市場：2026年至2032年全球市場預測（依來源類型、捐贈者類型、支付模式、受贈者年齡層和診所類型分類）

Donor Egg IVF Services Market by Source Type, Donor Type, Payment Model, Recipient Age Group, Clinic Type - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，捐卵子體外受精服務市場價值將達到 27.4 億美元，到 2026 年將成長至 30.1 億美元，到 2032 年將達到 54.6 億美元，複合年成長率為 10.31%。

主要市場統計數據
基準年 2025 27.4億美元
預計年份：2026年 30.1億美元
預測年份：2032年 54.6億美元
複合年成長率 (%) 10.31%

簡要介紹動態的供卵子體外受精生態系統，向領導者介紹策略決策中使用的臨床、商業性和營運重點。

體外受精捐卵子領域正經歷快速變革，其驅動力來自臨床實踐、患者群體和服務模式的同步演變。本執行摘要旨在為醫療保健高管、診所營運者、保險公司和投資者等相關人員提供關鍵洞察，幫助他們快速了解臨床方案、病人歷程和營運框架等方面的最新趨勢。

快速的臨床創新、數位化病人歷程以及不斷變化的監管預期，是如何重新定義體外受精服務和利用卵子捐贈的醫療服務提供者策略的？

體外受精捐卵子領域正經歷著一場變革，這得益於技術創新、監管改革以及患者期望的不斷變化，所有這些因素都在推動服務設計和交付方式的轉型。冷凍保存技術和檢查室流程的進步降低了結果的變異性，提高了可預測性，從而促進了冷凍捐卵子的使用，並催生了新的物流模式，在不影響臨床品質的前提下，擴大了服務範圍。

評估近期美國關稅措施如何重塑了關於卵子捐贈實踐、供應鏈韌性以及體外受精服務中患者成本負擔的考慮。

美國近期的貿易和關稅趨勢正對捐卵子體外受精服務的營運經濟效益和供應鏈穩定性產生直接和間接的累積影響。影響進口實驗室設備、冷凍保存耗材和專用醫療設備的關稅措施，使依賴全球供應商的診所的採購流程變得更加複雜，促使許多診所重新評估其供應商多元化、庫存策略和長期資本規劃。

深入了解來源類型、捐贈者關係、支付模式、接受者年齡層和診所形式如何影響臨床管道和服務經濟。

要理解市場的內部結構，最好採用層級細分法，這種方法會影響臨床通路、定價和病患體驗。卵子來源類型仍然是一個主要區別因素；傳統上，活卵子與供卵者和受卵者之間即時進行週期調整相關，而冷凍卵子則提供了柔軟性的排卵時間和更廣泛的地域覆蓋。在每個卵子來源類別中，選擇何種手術方式，例如體外受精（IVF）聯合或不聯合卵胞漿內單一精子注射（ICSI），會影響檢查室工作流程、資源分配和諮詢需求，進而影響治療時間安排和臨床調整需求。

實際的區域洞察揭示了美洲、歐洲、中東和非洲以及亞太地區的市場動態如何推動病患流量、診所策略和監管應對措施。

區域趨勢正對美洲、歐洲、中東和非洲以及亞太地區的臨床實踐模式、病患流動和法律規範產生重大影響。在美洲，來自國內外患者的強勁需求，加上私立診所格局的多樣性以及與保險公司之間不斷發展的對話，正促使醫療服務提供者優先考慮治療結果的透明度、患者資金籌措方案以及能夠適應跨境物流的綜合護理路徑。

公司層面的策略分析表明，臨床品質、整合服務和夥伴關係生態系統如何為使用捐卵子的體外受精服務創造永續的競爭優勢。

在捐卵子體外受精（IVF）領域，主要企業正透過結合卓越的臨床技術、垂直整合和以患者為中心的服務設計來脫穎而出。那些投資於專有捐卵者資料庫、完善的篩檢流程以及注重認證的品管系統的企業，往往能夠贏得更強大的病患信任，並獲得更多的出版夥伴關係。與基因檢測實驗室、冷凍保存供應商和物流服務商建立策略合作夥伴關係，使這些機構能夠提供端到端的解決方案，從而減少流程摩擦和治療結果的差異。

為診所營運者和醫療保健系統領導者提供切實可行的優先建議，以增強臨床韌性、與保險公司合作以及以患者為中心的服務提供。

為了在臨床和經濟逆境中蓬勃發展，產業領導者必須採取果斷且優先的行動，在提升臨床品質和病患信心的同時，增強營運彈性。首先，要實現供應鏈多元化，並建立關鍵設備和耗材的國內維護和庫存管理能力，以降低貿易中斷和關稅延誤的風險。同時，要投資於冷凍保存能力和檢驗的方案，從而實現靈活的排班，並擴大診所的地理採購範圍。

採用高度透明的混合方法研究途徑，結合相關人員訪談、臨床調查和監管趨勢分析，得出可操作且檢驗的產業見解。

本分析整合了混合方法研究設計中的洞見，該設計結合了與關鍵相關人員的對話以及對第二手資料的全面回顧。主要研究包括對臨床負責人、檢查室經理、採購負責人和患者權益倡導團體代表的結構化訪談，揭示了營運挑戰、與保險公司的互動以及患者體驗的趨勢。這些質性研究結果輔以有針對性的問卷調查，以了解診所層級在捐贈者招募、冷凍保存方案和遠端醫療整合方面的實踐。

結論是，該整合突顯了捐卵子體外受精服務中維持臨床卓越性和營運靈活性所必需的策略重點、風險領域和平衡方法。

總之，目前捐卵子體外受精的現況呈現出機會與風險交織的複雜局面，需要臨床醫師、保險公司和相關人員採取謹慎的策略應對措施。技術進步和冷凍保存技術的改進正在拓展臨床選擇，並催生更靈活的服務模式，而數位化診療路徑則有助於改善患者就診途徑和就醫體驗。同時，不斷變化的貿易政策、保險公司應對措施的不一致以及日益嚴格的倫理監管也帶來了營運和聲譽方面的風險，這些風險必須得到積極應對。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：捐卵子體外受精服務市場：依來源類型分類

  • 新鮮捐卵子
  • 冷凍捐卵子

第9章：捐卵子體外受精服務市場：依捐卵類型分類

  • 匿名的
  • 已知捐贈者
    • 朋友
    • 兄弟姊妹

第10章：捐卵子體外受精服務市場：依支付模式分類

  • 保險範圍
    • 全額賠償
    • 部分補償
  • 自費

第11章：捐卵子體外受精服務市場：依受者年齡層別分類

  • 35-45歲
  • 45歲或以上
  • 35歲以下

第12章：捐卵子體外受精服務市場：依診所類型分類

  • 綜合醫院
  • 不孕症治療專科診所
    • 鏈
    • 獨立的

第13章：捐卵子體外受精服務市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：捐卵子體外受精服務市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：捐卵子體外受精服務市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國捐卵子體外受精服務市場

第17章：中國捐卵子體外受精服務市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Akruti IVF Centre LLP
  • Apollo Fertility
  • Birla Fertility and IVF Center
  • CCRM North America, Inc.
  • Cloudnine Fertility
  • Cryos International A/S
  • Donor Egg Bank USA LLC
  • Fairfax Reproductive Services, LLC
  • Gaudium IVF Pvt. Ltd.
  • Genea Pty Ltd
  • Human Potential, Inc.
  • Indira IVF Hospital Pvt. Ltd.
  • Milann Fertility Centre
  • Morpheus Life Sciences Pvt. Ltd.
  • Nova IVF Fertility Pvt. Ltd.
  • Ovogene Ltd.
  • Prelude Fertility, Inc.
  • Raffles Medical Group Ltd.
  • SGF Fertility Services, LLC
  • Sims IVF Fertility Clinic Ltd.
  • The Boston IVF Collaborative, LLC
  • The Cape Fertility Clinic（Pty）Ltd.
  • Virtus Health Ltd.
  • Virtus Reproductive Partners, LLC
  • World Fertility Services Ltd.
Product Code: MRR-AD36CD898227

The Donor Egg IVF Services Market was valued at USD 2.74 billion in 2025 and is projected to grow to USD 3.01 billion in 2026, with a CAGR of 10.31%, reaching USD 5.46 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.74 billion
Estimated Year [2026] USD 3.01 billion
Forecast Year [2032] USD 5.46 billion
CAGR (%) 10.31%

Concise introduction framing the dynamic donor egg IVF ecosystem to orient leaders to clinical, commercial, and operational priorities for strategic decision-making

The donor egg IVF landscape is undergoing rapid transformation as clinical practice, patient demographics, and service delivery models evolve in parallel. This executive summary synthesizes the most critical insights for healthcare executives, clinic operators, payers, and investor stakeholders who require a concise, actionable synthesis of emerging dynamics across clinical protocols, patient journeys, and operational frameworks.

In crafting these insights, emphasis has been placed on clinical differentiation, patient access pathways, and the strategic responses of providers to regulatory and economic headwinds. The narrative that follows prioritizes clarity for decision-makers by translating complex clinical and commercial variables into strategic implications that can inform planning, partnerships, and investment. By focusing on the practical consequences of recent shifts in supply, demand, and policy, the analysis equips readers to make informed choices about service design, network expansion, and payer engagement.

Throughout the summary, attention is given to the drivers of change-technological advancement, evolving payer landscapes, demographic pressures, and cross-border patient flows-while also outlining actionable priorities for organizations intent on maintaining clinical excellence and commercial resilience. The approach balances clinical rigor with business pragmatism, offering insights that are immediately relevant to operational and strategic agendas.

How rapid clinical innovations, digital patient journeys, and evolving regulatory expectations are redefining donor egg IVF services and provider strategies

The donor egg IVF sector is being reshaped by a confluence of technological innovation, regulatory recalibration, and shifting patient expectations that together constitute transformative shifts in service design and delivery. Advances in cryopreservation techniques and laboratory protocols have reduced variability and improved predictability in outcomes, encouraging broader uptake of frozen donor eggs and enabling new logistics models that extend geographic reach without sacrificing clinical quality.

Concurrently, digital health platforms and telemedicine have streamlined initial patient engagement, psychosocial counseling, and coordination between sourcing clinics and treatment centers, thereby compressing timelines and lowering some barriers to access. Payer dialogues are maturing in parallel, with self-funded pathways remaining prominent while pockets of insurance coverage expand in jurisdictions where advocacy and policy alignment have progressed. These shifts are also prompting clinics to rethink bundled pricing and patient support services to improve transparency and continuity of care.

Ethical considerations and donor management protocols have become central to reputational risk and regulatory compliance. Amplified scrutiny around donor screening, informed consent, and long-term data governance is driving providers to adopt more rigorous accreditation and traceability frameworks. Finally, cross-border reproductive care patterns are evolving as patients weigh clinical quality, regulatory clarity, and cost, prompting clinics to develop integrated care pathways that include remote assessments, local follow-up arrangements, and coordinated logistics for embryo and sample transport.

Assessment of how recent United States tariff measures have reshaped procurement practices, supply chain resilience, and patient affordability considerations for IVF services

Recent trade and tariff developments in the United States have exerted a cumulative influence on the operational economics and supply chain stability of donor egg IVF services, with effects that are both direct and second-order. Tariff measures affecting imported laboratory equipment, cryopreservation consumables, and specialized medical devices have increased procurement complexity for clinics that rely on global vendors, prompting many to reassess vendor diversification, inventory strategies, and long-term capital planning.

These cost pressures have been met with strategic adjustments in procurement and clinical operations. Some providers have accelerated local sourcing where feasible, adopted longer inventory lead times, and invested in domestic maintenance capabilities to reduce reliance on cross-border shipment of critical parts. The tariff environment has also encouraged collaboration between clinics and manufacturers to explore alternative product specifications and compatible supply options that mitigate tariff exposure while preserving clinical standards.

On the demand side, tariff-induced cost inflation can indirectly affect patient affordability and the calculus of cross-border care. Patients evaluating treatment destinations are increasingly attentive to total cost of care, inclusive of logistics and potential customs-related delays. As a result, clinics that can demonstrate supply chain resilience, transparent pricing, and expedited logistics are positioned to sustain patient inflows. At the policy and payer levels, stakeholders are reassessing reimbursement contracts and cost-sharing frameworks to reflect changes in clinic operating cost structures influenced by trade policy dynamics.

Deep segmentation-driven insight that explains how source type, donor relationships, payer models, recipient age cohorts, and clinic formats shape clinical pathways and service economics

The market's internal architecture is best understood through layered segmentation that impacts clinical pathways, pricing, and patient experience. Source type remains a primary differentiator, with fresh donor eggs traditionally linked to immediate cycle coordination between donor and recipient and frozen donor eggs offering scheduling flexibility and broader geographic sourcing. Within each source category, procedural choices such as IVF with intracytoplasmic sperm injection and IVF without ICSI influence laboratory workflows, resource allocation, and counseling requirements, thereby affecting treatment timelines and clinical coordination needs.

Donor type introduces an alternate set of considerations. Anonymous donors underpin scalable recruitment programs and standardized screening workflows, while known donors-often friends or siblings-create unique legal, psychosocial, and clinical counseling needs that require tailored consent processes and family-centered support services. Payment model segmentation is equally consequential: insurance-covered pathways, whether full coverage or partial coverage, change the timing and complexity of approvals and prior authorization workflows, whereas self-funded patients typically navigate decisions differently, with a stronger focus on price transparency, financing options, and concierge-level support.

Recipient age group shapes clinical strategy and counseling priorities; patients under 35 may present different prognostic conversations than those in the 35 to 40, 41 to 45, or over 45 cohorts, influencing embryo transfer planning and adjunct therapies. Clinic type further differentiates market positioning and capability sets. General hospitals often bring integrated medical services and multidisciplinary care but may have less specialized donor recruitment capabilities, while specialized fertility clinics-whether part of a chain or independent-tend to emphasize brand-specific protocols, donor databases, and tailored patient navigation programs. Understanding how these segments intersect clarifies where operational investments will yield the greatest clinical and commercial returns.

Actionable regional intelligence revealing how Americas, Europe Middle East & Africa, and Asia-Pacific market dynamics drive patient flows, clinic strategies, and regulatory responses

Regional dynamics exert a profound influence on clinical practice patterns, patient mobility, and regulatory frameworks across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, a heterogeneous landscape of private clinics and evolving payer conversations is coupled with strong demand from domestic patients and international visitors, leading providers to emphasize outcome transparency, patient financing solutions, and integrated care pathways that accommodate cross-border logistics.

Across Europe, the Middle East & Africa, variance in regulatory regimes and cultural perspectives drives distinct demand pockets and referral flows. Clinics in jurisdictions with clear donor anonymity rules or supportive reimbursement frameworks often attract patients seeking predictable regulatory environments, while regions with stricter consent or data rules necessitate enhanced compliance capabilities and patient education programs. In the Asia-Pacific, demographic pressures and rising middle-class demand are encouraging rapid expansion of specialized fertility services, investment in cryopreservation infrastructure, and emergence of regional centers that combine clinical excellence with competitive pricing to serve both domestic and international patients.

These regional profiles are not static; they interact through cross-border patient flows, supplier networks, and regulatory harmonization efforts. Providers that align their operational models to regional strengths-whether through targeted marketing, partnerships with referral networks, or localized compliance frameworks-can better manage patient expectations and operational risks while capitalizing on each region's distinct demand drivers.

Strategic company-level analysis showing how clinical quality, integrated services, and partnership ecosystems are creating durable competitive advantages in donor egg IVF services

Leading organizations in the donor egg IVF arena are differentiating through a combination of clinical excellence, vertical integration, and patient-centric service design. Companies that have invested in proprietary donor databases, robust screening protocols, and accreditation-focused quality systems tend to command stronger patient trust and referral partnerships. Strategic alliances with genetic testing laboratories, cryopreservation suppliers, and logistic providers enable these organizations to offer end-to-end solutions that reduce friction and variability in outcomes.

Competition is also being shaped by service innovation. Clinics that integrate digital intake, remote counseling, and comprehensive psychosocial support position themselves as full-service providers capable of managing complex care journeys across geographies. At the same time, consolidation among specialized providers and selective partnerships with hospital systems create differentiated referral networks and access to multidisciplinary care for patients with concomitant medical needs. Operational excellence - reflected in transparent pricing, timely patient communication, and demonstrable quality metrics - remains a core differentiator in a market where reputation and outcomes drive patient decision-making.

Emerging players are leveraging targeted specialization and niche service offerings, such as donor matching algorithms, customizable donor anonymity options, and concierge coordination for out-of-region patients. These approaches broaden competitive strategies beyond price, enabling value-based differentiation that resonates with both self-funded patients and those navigating partial or full coverage pathways.

Practical and prioritized recommendations for clinic operators and health system leaders to strengthen clinical resilience, payer collaboration, and patient-centric service delivery

To thrive amid clinical and economic headwinds, industry leaders must take decisive, prioritized actions that reinforce clinical quality and patient trust while enhancing operational agility. First, diversify supply chains and develop domestic maintenance and inventory capabilities for critical equipment and consumables to reduce vulnerability to trade disruptions and tariff-induced delays. Parallel to this, invest in cryopreservation capacity and validated protocols that allow flexible scheduling and broaden the clinic's geographic sourcing footprint.

Second, deepen payer engagement through transparent outcome tracking and value-based contracting pilots where feasible, while also expanding patient financing options and clear pricing communication for self-funded individuals. Third, elevate digital patient journeys by integrating telehealth assessments, remote counseling, and centralized care coordination to compress timelines and improve adherence to treatment protocols. Fourth, strengthen donor governance through enhanced screening, consent management, and long-term data stewardship to address ethical concerns and regulatory scrutiny.

Fifth, pursue targeted partnerships with genetic testing laboratories, logistics providers, and referral networks to offer end-to-end continuity of care for cross-border patients. Finally, implement robust data analytics to monitor clinical performance, patient satisfaction, and operational KPIs, using these insights to iterate on care pathways and resource allocation decisions. Together, these actions will help organizations maintain high standards of care while adapting to shifting payer and policy environments.

Transparent mixed-methods research approach combining stakeholder interviews, clinic surveys, and regulatory synthesis to produce actionable and validated sector insights

The analysis synthesizes findings from a mixed-methods research design combining primary stakeholder engagement and comprehensive secondary review. Primary research included structured interviews with clinical leaders, laboratory directors, procurement specialists, and patient advocacy representatives to surface operational challenges, payer interactions, and patient experience trends. These qualitative insights were complemented by targeted surveys that captured clinic-level practices around donor recruitment, cryopreservation protocols, and telehealth integration.

Secondary research consisted of systematic review of regulatory guidance, professional society recommendations, and published clinical literature to validate best-practice models and ethical frameworks. Data triangulation techniques were applied to reconcile divergent perspectives and ensure that conclusions reflect both operational realities and clinical standards. Segment mapping was used to align insights with source type, donor relationships, payment modalities, recipient age cohorts, and clinic formats, enabling nuanced recommendations tailored to distinct provider archetypes.

Throughout the research process, emphasis was placed on methodological transparency, rigorous source validation, and stakeholder corroboration to ensure the findings are robust and operationally relevant. Confidentiality safeguards were maintained for interview participants, and synthesis prioritized actionable intelligence over speculative conjecture.

Concluding synthesis highlighting strategic priorities, risk areas, and the balanced approach required to sustain clinical excellence and operational agility in IVF services

In conclusion, the donor egg IVF landscape presents a complex mix of opportunity and risk that requires deliberate strategic responses from clinical providers, payers, and policy stakeholders. Technological advancements and improved cryopreservation fidelity are expanding clinical options and enabling more flexible service models, while digital care pathways are improving access and patient experience. At the same time, trade policy dynamics, payer variability, and heightened ethical scrutiny introduce operational and reputational risks that must be actively managed.

Organizations that prioritize supply chain resilience, rigorous donor governance, and transparent patient engagement will be better positioned to capture demand across both domestic and cross-border segments. Those that couple clinical excellence with differentiated service models - including integrated telehealth, strong partnerships, and outcome transparency - can build sustainable competitive advantages. The path forward requires a balanced focus on clinical outcomes, operational efficiency, and stakeholder collaboration to ensure that services remain accessible, safe, and aligned with evolving patient expectations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Donor Egg IVF Services Market, by Source Type

  • 8.1. Fresh Donor Eggs
  • 8.2. Frozen Donor Eggs

9. Donor Egg IVF Services Market, by Donor Type

  • 9.1. Anonymous
  • 9.2. Known
    • 9.2.1. Friend
    • 9.2.2. Sibling

10. Donor Egg IVF Services Market, by Payment Model

  • 10.1. Insurance-Covered
    • 10.1.1. Full Coverage
    • 10.1.2. Partial Coverage
  • 10.2. Self-Funded

11. Donor Egg IVF Services Market, by Recipient Age Group

  • 11.1. 35 To 45
  • 11.2. Over 45
  • 11.3. Under 35

12. Donor Egg IVF Services Market, by Clinic Type

  • 12.1. General Hospitals
  • 12.2. Specialized Fertility Clinics
    • 12.2.1. Chain
    • 12.2.2. Independent

13. Donor Egg IVF Services Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Donor Egg IVF Services Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Donor Egg IVF Services Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Donor Egg IVF Services Market

17. China Donor Egg IVF Services Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Akruti IVF Centre LLP
  • 18.6. Apollo Fertility
  • 18.7. Birla Fertility and IVF Center
  • 18.8. CCRM North America, Inc.
  • 18.9. Cloudnine Fertility
  • 18.10. Cryos International A/S
  • 18.11. Donor Egg Bank USA LLC
  • 18.12. Fairfax Reproductive Services, LLC
  • 18.13. Gaudium IVF Pvt. Ltd.
  • 18.14. Genea Pty Ltd
  • 18.15. Human Potential, Inc.
  • 18.16. Indira IVF Hospital Pvt. Ltd.
  • 18.17. Milann Fertility Centre
  • 18.18. Morpheus Life Sciences Pvt. Ltd.
  • 18.19. Nova IVF Fertility Pvt. Ltd.
  • 18.20. Ovogene Ltd.
  • 18.21. Prelude Fertility, Inc.
  • 18.22. Raffles Medical Group Ltd.
  • 18.23. SGF Fertility Services, LLC
  • 18.24. Sims IVF Fertility Clinic Ltd.
  • 18.25. The Boston IVF Collaborative, LLC
  • 18.26. The Cape Fertility Clinic (Pty) Ltd.
  • 18.27. Virtus Health Ltd.
  • 18.28. Virtus Reproductive Partners, LLC
  • 18.29. World Fertility Services Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DONOR EGG IVF SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DONOR EGG IVF SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA DONOR EGG IVF SERVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FRESH DONOR EGGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FRESH DONOR EGGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FRESH DONOR EGGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FROZEN DONOR EGGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FROZEN DONOR EGGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FROZEN DONOR EGGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY ANONYMOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY ANONYMOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY ANONYMOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FRIEND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FRIEND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FRIEND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SIBLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SIBLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SIBLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FULL COVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FULL COVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY FULL COVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY PARTIAL COVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY PARTIAL COVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY PARTIAL COVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SELF-FUNDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SELF-FUNDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SELF-FUNDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY 35 TO 45, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY 35 TO 45, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY 35 TO 45, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY OVER 45, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY OVER 45, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY OVER 45, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY UNDER 35, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY UNDER 35, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY UNDER 35, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY CHAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY CHAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY CHAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY INDEPENDENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS DONOR EGG IVF SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 144. GCC DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GCC DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. GCC DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. GCC DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 148. GCC DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 149. GCC DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 150. GCC DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GCC DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. GCC DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 171. G7 DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. G7 DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. G7 DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. G7 DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 175. G7 DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 176. G7 DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 177. G7 DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 178. G7 DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. G7 DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 180. NATO DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. NATO DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. NATO DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NATO DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 184. NATO DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 185. NATO DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 186. NATO DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. NATO DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. NATO DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL DONOR EGG IVF SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA DONOR EGG IVF SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA DONOR EGG IVF SERVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA DONOR EGG IVF SERVICES MARKET SIZE, BY DONOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA DONOR EGG IVF SERVICES MARKET SIZE, BY KNOWN, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA DONOR EGG IVF SERVICES MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA DONOR EGG IVF SERVICES MARKET SIZE, BY INSURANCE-COVERED, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA DONOR EGG IVF SERVICES MARKET SIZE, BY RECIPIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA DONOR EGG IVF SERVICES MARKET SIZE, BY CLINIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA DONOR EGG IVF SERVICES MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, 2018-2032 (USD MILLION)